Mutations in genes encoding the cellular tumor antigen p53 (TP53), cyclin-dependent kinase inhibitor 2A (CDKN2A), phosphatase and tensin homolog (PTEN), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA), retinoblastoma (RB1), GTPase KRas (KRAS), estrogen receptor (ESR1), MYC proto-oncogene protein (MYC), and serine/threonine-protein kinase B-raf (BRAF) were linked with the tumor metastasis process. The gene discussed is CDKN2A; the disease is neoplasm.